147 related articles for article (PubMed ID: 22017545)
21. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
Bhatt KV; Hu R; Spofford LS; Aplin AE
Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
[TBL] [Abstract][Full Text] [Related]
22. High-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1.
Ungermannova D; Lee J; Zhang G; Dallmann HG; McHenry CS; Liu X
J Biomol Screen; 2013 Sep; 18(8):910-20. PubMed ID: 23589337
[TBL] [Abstract][Full Text] [Related]
23. Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells.
Westbrook L; Manuvakhova M; Kern FG; Estes NR; Ramanathan HN; Thottassery JV
Cancer Res; 2007 Dec; 67(23):11393-401. PubMed ID: 18056467
[TBL] [Abstract][Full Text] [Related]
24. Altered expression of p27(Kip1) -interacting cell-cycle regulators in the adult testicular germ cell tumors: potential role in tumor development and histological progression.
Miyai K; Yamamoto S; Iwaya K; Asano T; Tamai S; Tsuda H; Matsubara O
APMIS; 2012 Nov; 120(11):890-900. PubMed ID: 23009113
[TBL] [Abstract][Full Text] [Related]
25. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I
J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183
[TBL] [Abstract][Full Text] [Related]
26. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.
Halfter H; Friedrich M; Resch A; Kullmann M; Stögbauer F; Ringelstein EB; Hengst L
Cancer Res; 2006 Jul; 66(13):6530-9. PubMed ID: 16818624
[TBL] [Abstract][Full Text] [Related]
27. Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation.
Salamina M; Montefiore BC; Liu M; Wood DJ; Heath R; Ault JR; Wang LZ; Korolchuk S; Baslé A; Pastok MW; Reeks J; Tatum NJ; Sobott F; Arold ST; Pagano M; Noble MEM; Endicott JA
J Mol Biol; 2021 Mar; 433(5):166795. PubMed ID: 33422522
[TBL] [Abstract][Full Text] [Related]
28. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY
Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491
[TBL] [Abstract][Full Text] [Related]
29. Cks1 promotion of S phase entry and proliferation is independent of p27Kip1 suppression.
Hoellein A; Graf S; Bassermann F; Schoeffmann S; Platz U; Hölzlwimmer G; Kröger M; Peschel C; Oostendorp R; Quintanilla-Fend L; Keller U
Mol Cell Biol; 2012 Jul; 32(13):2416-27. PubMed ID: 22508990
[TBL] [Abstract][Full Text] [Related]
30. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase.
Hao B; Zheng N; Schulman BA; Wu G; Miller JJ; Pagano M; Pavletich NP
Mol Cell; 2005 Oct; 20(1):9-19. PubMed ID: 16209941
[TBL] [Abstract][Full Text] [Related]
31. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.
Nakayama K; Nagahama H; Minamishima YA; Matsumoto M; Nakamichi I; Kitagawa K; Shirane M; Tsunematsu R; Tsukiyama T; Ishida N; Kitagawa M; Nakayama K; Hatakeyama S
EMBO J; 2000 May; 19(9):2069-81. PubMed ID: 10790373
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells.
Lee SH; McCormick F
J Mol Med (Berl); 2005 Apr; 83(4):296-307. PubMed ID: 15605273
[TBL] [Abstract][Full Text] [Related]
33. A negatively charged amino acid in Skp2 is required for Skp2-Cks1 interaction and ubiquitination of p27Kip1.
Wang W; Ungermannova D; Chen L; Liu X
J Biol Chem; 2003 Aug; 278(34):32390-6. PubMed ID: 12813041
[TBL] [Abstract][Full Text] [Related]
34. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
[TBL] [Abstract][Full Text] [Related]
35. Molecular and biochemical characterization of the Skp2-Cks1 binding interface.
Wang W; Ungermannova D; Chen L; Liu X
J Biol Chem; 2004 Dec; 279(49):51362-9. PubMed ID: 15452136
[TBL] [Abstract][Full Text] [Related]
36. Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation.
Kitajima S; Kudo Y; Ogawa I; Bashir T; Kitagawa M; Miyauchi M; Pagano M; Takata T
Am J Pathol; 2004 Dec; 165(6):2147-55. PubMed ID: 15579456
[TBL] [Abstract][Full Text] [Related]
37. The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27.
Ganoth D; Bornstein G; Ko TK; Larsen B; Tyers M; Pagano M; Hershko A
Nat Cell Biol; 2001 Mar; 3(3):321-4. PubMed ID: 11231585
[TBL] [Abstract][Full Text] [Related]
38. Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.
Gupta P; Zhao H; Hoang B; Schwartz EL
Br J Cancer; 2022 Oct; 127(6):969-975. PubMed ID: 35752713
[TBL] [Abstract][Full Text] [Related]
39. Specific small molecule inhibitors of Skp2-mediated p27 degradation.
Wu L; Grigoryan AV; Li Y; Hao B; Pagano M; Cardozo TJ
Chem Biol; 2012 Dec; 19(12):1515-24. PubMed ID: 23261596
[TBL] [Abstract][Full Text] [Related]
40. The expression of the ubiquitin ligase subunit Cks1 in human breast cancer.
Slotky M; Shapira M; Ben-Izhak O; Linn S; Futerman B; Tsalic M; Hershko DD
Breast Cancer Res; 2005; 7(5):R737-44. PubMed ID: 16168119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]